Invenomic Capital Management
Invenomic Capital Management reported 116 stocks worth $2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are UHS (3.9%), GPN (3.4%) and AMTM (3.3%). Compared with Q2 2026, the fund opened new positions in AMTM, GDDY and OCTV, added to UHS, ST and OMC, trimmed GPN, SPSC and XRAY and sold out of BDX, BILL and PATH.
Latest filing: what Invenomic Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() UHS Universal Hlth Svcs Inc | $79.6M | 3.9% | 457K | +29K (+7%) | 5 of 8 | |
| 2 | ![]() GPN Global Pmts Inc | $68.2M | 3.4% | 835K | −46K (−5%) | 8 of 8 | |
| 3 | ![]() AMTM Amentum Holdings Inc | $66.7M | 3.3% | 3.7M | New position | 1 of 8 | |
| 4 | ![]() ST Sensata Technologies Hldg PL | $62.1M | 3.0% | 1.5M | +1M (+218%) | 8 of 8 | |
| 5 | ![]() GDDY Godaddy Inc | $56.6M | 2.8% | 593K | New position | 1 of 8 | |
| 6 | ![]() OMC Omnicom Group Inc | $55M | 2.7% | 747K | +268K (+56%) | 6 of 8 | |
| 7 | ![]() FIS Fidelity Natl Information SV | $54.2M | 2.7% | 1.6M | +587K (+55%) | 7 of 8 | |
| 8 | ![]() CHTR Charter Communications Inc N | $51.8M | 2.5% | 467K | +185K (+65%) | 2 of 8 | |
| 9 | ![]() PVH Pvh Corporation | $50.1M | 2.5% | 676K | +101K (+18%) | 7 of 8 | |
| 10 | ![]() SPSC Sps Comm Inc | $49.7M | 2.4% | 602K | −267K (−31%) | 3 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() BDX Becton Dickinson & Co | $41.3M | 273K |
![]() BILL Bill Holdings Inc | $32.9M | 909K |
![]() PATH Uipath Inc | $19.4M | 1.8M |
![]() FIVN FIVE9 Inc | $19M | 893K |
![]() HAE Haemonetics Corp Mass | $16.2M | 216K |
🔒 Free account: see all 30.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
![]() TLT Ishares TR | Call | $272K | 3,500 | 0 |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Invenomic Capital Management 13F FAQ
What does Invenomic Capital Management own?
Invenomic Capital Management reported 116 stocks worth $2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are UHS (3.9%), GPN (3.4%) and AMTM (3.3%). The table above lists every position in the filing (the top 10 without an account).
What did Invenomic Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 37 new positions, 46 added to, 30 trimmed and 36 sold out. New positions include AMTM, GDDY and OCTV. It sold all of BDX, BILL and PATH.
When will Invenomic Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Invenomic Capital Management's portfolio worth?
The Q3 2026 filing reports $2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.

























